Tizanidine HCl Tablets — Class II drug recall D-0750-2021
Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2021-08-25, distributed nationwide. Failed Tablet/Capsule Specification: Some tablets are shaved
| Recall number | D-0750-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2021-07-19 |
| Classified | 2021-08-18 |
| Reported by FDA | 2021-08-25 |
| Terminated | 2022-12-21 |
| Distributed | Nationwide (US) |
| Quantity | 37,560 bottles |
| NDC | 55111-0179, 55111-0179-03, 55111-0179-10, 55111-0179-15, 55111-0179-30, 55111-0180, 55111-0180-03, 55111-0180-10, 55111-0180-15, 55111-0180-30 |
| Lot numbers | T2000471 |
| Expiration dates | 2023-09 |
Product
Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.
Reason for recall
Failed Tablet/Capsule Specification: Some tablets are shaved
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0750-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.